Full-Time
Confirmed live in the last 24 hours
Provider of medical supplies and healthcare solutions
$73.8k - $107.1kAnnually
Junior, Mid
Sharon Hill, PA, USA
Candidate must be located in the Midwest or Northeast region and will report to a location on a hybrid schedule.
You match the following Medline's candidate preferences
Employers are more likely to interview you if you match these preferences:
Medline provides medical supplies and healthcare solutions to various clients, including hospitals, nursing homes, and home health agencies. The company offers a wide range of products such as protective gear, wound care items, diabetes care supplies, and home diagnostics. Medline operates on a business-to-business model, selling directly to healthcare providers and institutions. Its revenue comes from the sale of these medical supplies and equipment, along with value-added services like supply chain management and educational resources. Medline distinguishes itself from competitors through its strong focus on sustainability and resilience, demonstrated by significant investments in domestic supply chain infrastructure. The company's goal is to consistently deliver value and support to its clients, as evidenced by accolades like the Preferred Supplier of the Year award from the University of Texas System Supply Chain Alliance.
Company Size
5,001-10,000
Company Stage
Grant
Total Funding
$486.4K
Headquarters
Mundelein, Illinois
Founded
1966
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Life Insurance
Disability Insurance
401(k) Company Match
Paid Vacation
Paid Sick Leave
Investment bankers are reportedly preparing for a dealmaking uptick in equity capital markets this year. Optimism among Wall Street’s banks is being fueled by a promising stable of initial public offerings (IPOs) by high-profile companies, Reuters reported late Friday (Jan. 10). Among these companies are liquified natural gas producer Venture Global, medical supplier Medline, and cybersecurity firm Sailpoint, the report said, citing sources familiar with the matter
New reports claim that medical supply company Medline Industries is planning for an initial public offering (IPO) as early as Q2 2025.
Medline named to Best in Business list; CEO Jim Boyle named to 2024 100 Most Influential People in Healthcare listNORTHFIELD, Ill., Dec. 9, 2024 /PRNewswire/ -- Medline is proud to announce two prestigious accolades from Modern Healthcare. Medline CEO Jim Boyle has been named one of the 100 Most Influential People in Healthcare for 2024, and Medline has been recognized as one of the Best in Business for 2024 in the supply chain category. These honors highlight exceptional leadership and innovation driving the healthcare industry forward
Medline could raise $5B in a 2025 IPO, report says.
Northfield, Ill., Nov. 19, 2024 - Medline today announced that it has expanded its medical surgical prime vendor agreement with Northern California-based healthcare network Sutter Health to include lab and environmental services (EVS).
Medical equipment and supply manufacturer Medline Industries confidentially submitted plans for a proposed initial public offering, potentially setting the stage for a blockbuster public debut next year.
Medical supply firm Medline aims to raise over $5 billion in 2025 IPO, sources say.
Will 2025 bring about a revival in the initial public offering (IPO) market?. As the Financial Times (FT) reported Sunday (Jan. 5), it’s a rebound Wall Street banks are preparing for, as private equity companies turn to the equities markets to offload some of their high-profile holdings. The report noted that a number of private equity-backed firms have already filed IPO paperwork, among them the medical devices company Medline and software maker Genesys
Medline CEO Jim Boyle has been named one of the 100 Most Influential People in Healthcare for 2024, and Medline has been recognized as one of the Best in Business for 2024 in the supply chain category.
Current President Chief Operating Officer (COO) to retire in 2025; New Chief Product Officer and new COO named. NORTHFIELD, Ill., Nov. 22, 2024 /PRNewswire/ -- Medline today announced a series of leadership changes, including that Jim Pigott (currently President COO) will retire from the company at the end of 2025. Additionally, Amanda Laabs (currently EVP, Medline Brand) is being promoted to Chief Product Officer, and Steve Miller (currently EVP, Supply Chain) is being promoted to the role of Chief Operating Officer, both effective January 1, 2025. "Jim Pigott has been instrumental to our success as a company, and his leadership has helped Medline accelerate its growth and expand its impact in meaningful ways," said Jim Boyle, CEO of Medline. "We are appreciative of Jim staying on through the transition next year, and we wish him all the best in the next chapter."